SCHEDULE: Vanguard Group Amends ResMed Stake to Zero

The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in ResMed Inc. following an internal realignment.

Summary

• The Vanguard Group filed Amendment No. 14 to its Schedule 13G for ResMed Inc. Common Stock.
• The filing reports 0.00 shares beneficially owned, representing 0% of the class of securities.
• This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these disaggregated subsidiaries and/or business divisions.
• The holdings previously reported were in the form of depository receipts.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral for ResMed Inc., as it primarily reflects an internal organizational change at The Vanguard Group rather than a change in investment thesis or a divestment of the underlying assets.

Future Outlook

No forward-looking statements or guidance regarding ResMed Inc.'s performance or The Vanguard Group's future investment intentions are provided in this filing.

Management Comments

• "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release."
• "Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that institutional investors like The Vanguard Group frequently adjust their internal reporting structures, which can lead to changes in beneficial ownership filings without necessarily indicating a change in overall investment strategy or sentiment towards the underlying company, ResMed Inc. This is a procedural update rather than a strategic divestment.

Stakeholder Impact

• Shareholders of ResMed Inc.: Minimal direct impact, as the underlying investment by Vanguard-affiliated entities may still exist, just reported differently by separate entities.
• The Vanguard Group: Reflects an internal reporting structure change, aligning with SEC guidance for disaggregated reporting.

Next Steps

• Certain subsidiaries or business divisions of The Vanguard Group, Inc. will report their beneficial ownership separately in future filings.

Key Dates

Keywords

ResMed Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, SEC Filing, Investment Adviser, Common Stock, Institutional Ownership